Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: Results of the HANE study

British Medical Journal

Volumn 315, Issue 7101, 1997, Pages 154-159

  Philipp, Thomas ^a   Anlauf, Manfred ^b   Distler, Armin ^c   Holzgreve, Heinrich ^d   Michaelis, Joerg ^e   Wellek, Stefan ^f  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Zentralkrankenhaus Reinkenheide   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f Abteilung Biostatistik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; ENALAPRIL; HYDROCHLOROTHIAZIDE; NITRENDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; MUSCLE CRAMP; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030762672     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7101.154     Document Type: Article

References (20)

1. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985;291:97-104.
2. Management Committee of The Australian therapeutic trial in mild hypertension. Report. Lancet 1980;i:1261-7.
3. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. 1. Reduction in mortality of persons with high blood pressure including mild hypertension. JAMA 1979;242:2562-71.
4. Collins R, Petro R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
5. 1993 Guidelines for the management of mild hypertension. J Hypertens 1993;11:905-18.
6. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993;306:983.
7. Deutsche Liga zur Bekampfung des hohen Blutdruckes (German Society of Hypertension). Empfehlungen zur Hochdruckbehandlung in der Praxas und zur Behandlung hypertensiver Notfälle. 9th ed. Heidelberg: German Society of Hypertension, 1994.
8. Hypertension Guidelines Committee. South Australian Faculty, Royal Australian College of General Practitioners. Guidelines endorsed by the High Blood Pressure Research Council of Australia. Adelaide: South Australian Faculty, Royal Australian College of General Practitioners, 1991.
9. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of mild hypertension study. Final results. JAMA 1993;270:713-24.
10. Materson BJ, Reda J, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-21.
11. Wassertheil-Smoller S, Oberman A, Blaufox MD, Langfort HG, Davis BR, Wylie-Rosett J. The trial of antihypertensive interventions and management (TAIM) study: final results with regard to blood pressure, cardiovascular risk, and quality of life. Am J Hypertens 1992;5:37-44.
12. Holzgreve H, Distler A, Michaelis J, Philipp T, Wellek S. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. BMJ 1989;299:881-6.
13. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
14. Robertson JIS. Comparative studies in hypertension: some fallacious claims of age-related drug effects. J Hypertens 1990;8(suppl 4):559-61.
15. Mann in 't Veld AJ, van den Meiracker AH, Schalekamp MADH. Age dependency of blood pressure response to antihypertensive treatment: some methodological considerations and observations on five β-adrenoceptor antagonists under different experimental conditions. J Cardiovasc Pharmacol 1988;12(suppl 8):593-7.
16. Buhler FR. Age and cardiovascular response adaptation. Determinants of the antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers. Hypertension 1983;5(suppl III):94-100.
17. Drayer JIM, Weber MA, Sealey LE, Laragher J, et al. Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics. Am J Med Sci 1981;281:135-42.
18. Saunders E, Weir MR, Kong BW. A comparison of the efficacy and safety of a β-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990;150:1707-13.
19. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical (ATC) classification index (including defined daily doses (DDDs) for plain substances. Oslo: World Health Organisation, 1993.
20. Mutti E, Trazzi S, Omboni S, Parati G, Mancia G. Effect of placebo on 24 h non-invasive ambulatory blood pressure. J Hypertens 1991;9:361-4.